These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

178 related articles for article (PubMed ID: 1451113)

  • 1. The bcr-abl gene in chronic myelogenous leukaemia.
    Sawyers CL
    Cancer Surv; 1992; 15():37-51. PubMed ID: 1451113
    [TBL] [Abstract][Full Text] [Related]  

  • 2. BCR gene expression blocks Bcr-Abl induced pathogenicity in a mouse model.
    Lin F; Monaco G; Sun T; Liu J; Lin H; Stephens C; Belmont J; Arlinghaus RB
    Oncogene; 2001 Apr; 20(15):1873-81. PubMed ID: 11313935
    [TBL] [Abstract][Full Text] [Related]  

  • 3. The BCR gene and philadelphia chromosome-positive leukemogenesis.
    Laurent E; Talpaz M; Kantarjian H; Kurzrock R
    Cancer Res; 2001 Mar; 61(6):2343-55. PubMed ID: 11289094
    [No Abstract]   [Full Text] [Related]  

  • 4. Intrinsic regulation of the interactions between the SH3 domain of p85 subunit of phosphatidylinositol-3 kinase and the protein network of BCR/ABL oncogenic tyrosine kinase.
    Ren SY; Xue F; Feng J; Skorski T
    Exp Hematol; 2005 Oct; 33(10):1222-8. PubMed ID: 16219545
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Expression of a truncated first exon BCR sequence in chronic myelogenous leukemia cells blocks cell growth and induces cell death.
    Wang Y; Liu J; Wu Y; Luo W; Lin SH; Lin H; Hawk N; Sun T; Guo JQ; Estrov Z; Talpaz M; Champlin R; Arlinghaus RB
    Cancer Res; 2001 Jan; 61(1):138-44. PubMed ID: 11196151
    [TBL] [Abstract][Full Text] [Related]  

  • 6. BCR-ABL-induced oncogenesis is mediated by direct interaction with the SH2 domain of the GRB-2 adaptor protein.
    Pendergast AM; Quilliam LA; Cripe LD; Bassing CH; Dai Z; Li N; Batzer A; Rabun KM; Der CJ; Schlessinger J
    Cell; 1993 Oct; 75(1):175-85. PubMed ID: 8402896
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Clonal succession and deletion of bcr/abl sequences in chronic myelogenous leukemia with recurrent lymphoid blast crisis.
    Laneuville P; Sullivan AK
    Leukemia; 1991 Sep; 5(9):752-6. PubMed ID: 1943228
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Molecular insights into the Philadelphia translocation.
    Heisterkamp N; Groffen J
    Hematol Pathol; 1991; 5(1):1-10. PubMed ID: 2050600
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Philadelphia chromosome-positive leukaemia: the translocated genes and their gene products.
    Allen PB; Morgan GJ; Wiedemann LM
    Baillieres Clin Haematol; 1992 Oct; 5(4):897-930. PubMed ID: 1308169
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Specific point mutations that activate v-abl are not found in Philadelphia-negative chronic myeloid leukaemia, Philadelphia-negative acute lymphoblastic leukaemia or blast transformation of chronic myeloid leukaemia.
    Melo JV; Goldman JM
    Leukemia; 1992 Aug; 6(8):786-90. PubMed ID: 1353550
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Bcr: a negative regulator of the Bcr-Abl oncoprotein in leukemia.
    Arlinghaus RB
    Oncogene; 2002 Dec; 21(56):8560-7. PubMed ID: 12476302
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Bcr and Abl interaction: oncogenic activation of c-Abl by sequestering Bcr.
    Ling X; Ma G; Sun T; Liu J; Arlinghaus RB
    Cancer Res; 2003 Jan; 63(2):298-303. PubMed ID: 12543778
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Chronic myelocytic leukemia--Part I: History, clinical presentation, and molecular biology.
    Randolph TR
    Clin Lab Sci; 2005; 18(1):38-48. PubMed ID: 15747785
    [TBL] [Abstract][Full Text] [Related]  

  • 14. P210 BCR-ABL is complexed to P160 BCR and ph-P53 proteins in K562 cells.
    Campbell ML; Li W; Arlinghaus RB
    Oncogene; 1990 May; 5(5):773-6. PubMed ID: 2140598
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Different methylation patterns of the M-BCR gene in myeloblastic and lymphoblastic crisis of chronic myelocytic leukemia.
    Ge X; Tanaka K; Kamada N
    Chin Med J (Engl); 1996 Apr; 109(4):300-3. PubMed ID: 8758292
    [TBL] [Abstract][Full Text] [Related]  

  • 16. A study on the incidence of ABL gene deletion on derivative chromosome 9 in chronic myelogenous leukemia by interphase fluorescence in situ hybridization and its association with disease progression.
    Lee DS; Lee YS; Yun YS; Kim YR; Jeong SS; Lee YK; She CJ; Yoon SS; Shin HR; Kim Y; Cho HI
    Genes Chromosomes Cancer; 2003 Jul; 37(3):291-9. PubMed ID: 12759927
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Interpretation of submicroscopic deletions of the BCR or ABL gene should not depend on extra signal-FISH: problems in interpretation of submicroscopic deletion of the BCR or ABL gene with extra signal-FISH.
    Kim YR; Cho HI; Yoon SS; Park S; Kim BK; Lee YK; Chun H; Kim HC; Lee DS
    Genes Chromosomes Cancer; 2005 May; 43(1):37-44. PubMed ID: 15723338
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Selective inhibition of cell proliferation and BCR-ABL phosphorylation in acute lymphoblastic leukemia cells expressing Mr 190,000 BCR-ABL protein by a tyrosine kinase inhibitor (CGP-57148).
    Beran M; Cao X; Estrov Z; Jeha S; Jin G; O'Brien S; Talpaz M; Arlinghaus RB; Lydon NB; Kantarjian H
    Clin Cancer Res; 1998 Jul; 4(7):1661-72. PubMed ID: 9676840
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Subcellular localization of Bcr, Abl, and Bcr-Abl proteins in normal and leukemic cells and correlation of expression with myeloid differentiation.
    Wetzler M; Talpaz M; Van Etten RA; Hirsh-Ginsberg C; Beran M; Kurzrock R
    J Clin Invest; 1993 Oct; 92(4):1925-39. PubMed ID: 8408645
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Mechanisms of BCR-ABL in the pathogenesis of chronic myelogenous leukaemia.
    Ren R
    Nat Rev Cancer; 2005 Mar; 5(3):172-83. PubMed ID: 15719031
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.